<DOC>
	<DOCNO>NCT00822588</DOCNO>
	<brief_summary>The study prospective , control , randomise assessor blind study investigate need bank blood transfusion could reduce patient , undergo primary revision total hip replacement surgery , receive blood back medical device Sangvia . A comparison need bank blood make patient either receive blood back .</brief_summary>
	<brief_title>Comparison Need Bank Blood Between Patients Undergoing Total Hip Surgery That Either Receive Their Own Blood Back Not</brief_title>
	<detailed_description />
	<criteria>Provision inform consent Scheduled primary secondary , cement noncemented , total hip arthroplasty Classified ASA Physical Status Classification System class P1 , P2 P3 accord American Society Anaesthesiology . Involvement plan conduct study ( applies Astra Tech staff staff study site ) Previous enrollment randomisation treatment present study Expected confirm participation another clinical study , may interfere present study , study period Suspected severe noncompliance protocol judge investigator Current symptom haemophilia Current symptom hyperkalaemia Current symptom systemic infection local infection operation field Current symptom impair renal function include creatinine/clearance level normal reference value History presence malignant disease propensity systemic spread last 5 year Current expect use cytotoxic drug Current untreated anaemia ( e.g . sickle cell anaemia ) , i.e . Hb concentration &lt; 11 g/dl ( 7 mmol/l ) Use recombinant erythopoetin Use aprotinin and/or fibrin sealant Use autologous blood transfusion SangviaÂ® system ( e.g . CellSaver , predonation , acute normovolemic haemodilution etc . ) Women childbearing age Fractures Revision/secondary total hip surgery expect serious bone grafting</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>